Correlation Between ATyr Pharma and Monte Rosa

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Monte Rosa Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Monte Rosa.

Diversification Opportunities for ATyr Pharma and Monte Rosa

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between ATyr and Monte is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Monte Rosa go up and down completely randomly.

Pair Corralation between ATyr Pharma and Monte Rosa

Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the Monte Rosa. In addition to that, ATyr Pharma is 1.28 times more volatile than Monte Rosa Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  530.00  in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would earn a total of  316.00  from holding Monte Rosa Therapeutics or generate 59.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy44.02%
ValuesDaily Returns

ATyr Pharma  vs.  Monte Rosa Therapeutics

 Performance 
       Timeline  
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

ATyr Pharma and Monte Rosa Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATyr Pharma and Monte Rosa

The main advantage of trading using opposite ATyr Pharma and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.
The idea behind ATyr Pharma and Monte Rosa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges